| Host Genetics at the intersection of Autoimmunity and COVID-19: A potential key for heterogeneous COVID-19 severity T Karaderi, H Bareke, I Kunter, A Seytanoglu, I Cagnan, D Balci, B Barin, ... Frontiers in Immunology 11, 2020 | 37 | 2020 |
| GnRH receptor activation competes at a low level with growth signaling in stably transfected human breast cell lines K Morgan, C Meyer, N Miller, AH Sims, I Cagnan, D Faratian, DJ Harrison, ... BMC cancer 11 (1), 1-13, 2011 | 15 | 2011 |
| Bone marrow mesenchymal stem cells carrying fancd2 mutation differ from the other fanconi anemia complementation groups in terms of TGF-β1 Production I Cagnan, A Gunel-Ozcan, F Aerts-Kaya, N Ameziane, B Kuskonmaz, ... Stem Cell Reviews and Reports 14 (3), 425-437, 2018 | 14 | 2018 |
| Dual Effect of Glucocorticoid-Induced Tumor Necrosis Factor–Related Receptor Ligand Carrying Mesenchymal Stromal Cells on Small Cell Lung Cancer: A Preliminary in vitro Study CZ Kopru, I Cagnan, I Akar, G Esendagli, P Korkusuz, A Gunel-Ozcan Cytotherapy 20 (7), 930-940, 2018 | 9 | 2018 |
| CHRNA5 belongs to the secondary estrogen signaling network exhibiting prognostic significance in breast cancer H Shehwana, AG Keskus, SE Ozdemir, AA Acikgöz, R Biyik-Sit, I Cagnan, ... Cellular Oncology, 1-20, 2021 | 8 | 2021 |
| PKNOX2 expression and regulation in the bone marrow mesenchymal stem cells of Fanconi anemia patients and healthy donors I Cagnan, E Cosgun, O Konu, D Uckan, A Gunel-Ozcan Molecular biology reports 46 (1), 669-678, 2019 | 6 | 2019 |
| Global miRNA expression of bone marrow mesenchymal stem/stromal cells derived from Fanconi anemia patients I Cagnan, M Keles, AG Keskus, M Tombaz, OB Sahan, F Aerts-Kaya, ... Human Cell, 1-14, 2021 | 4 | 2021 |
| G-CSF treatment of healthy pediatric donors affects their hematopoietic microenvironment through changes in bone marrow plasma cytokines and stromal cells F Aerts-Kaya, E Kilic, S Köse, G Aydin, I Cagnan, B Kuskonmaz, ... Cytokine 139, 155407, 2021 | 4 | 2021 |
| Stably expressed reference genes during differentiation of bone marrow-derived mesenchymal stromal cells I Cagnan, FA KAYA, FD ÇETİNKAYA, A ÖZCAN Turkish Journal of Biology 41 (1), 88-97, 2017 | 4 | 2017 |
| Predictors and trends of Caesarean section and breastfeeding in the Eastern Mediterranean region: Data from the cross-sectional Cyprus Women’s Health Research (COHERE) Initiative B Swift, B Taneri, I Cagnan, CM Becker, KT Zondervan, MA Quigley, ... Plos one 18 (7), e0287469, 2023 | 3 | 2023 |
| miRNA Expression Profiling in Mesenchymal Stromal/Stem Cells Derived from G-CSF Primed Bone Marrows A Gunel-Ozcan, I Cagnan, E Kansu, D Uckan Blood, The Journal of the American Society of Hematology 124 (21), 5140-5140, 2014 | 1 | 2014 |
| Hox and Tale Transcrıptıon Factors in Fanconı Anemıa Bone-Marrow Mesenchymal Stem Cells: Gene Expressıon and Proteın Interactıons I Çağnan Sağlık Bilimleri Enstitüsü, 2018 | | 2018 |
| TGF-β1 Production By Bone Marrow Mesenchymal Stem Cells of FANCD2 Differs from Other Fanconi Anemia Complementation Groups I Cagnan, A Gunel-Ozcan, F Aerts-Kaya, N Ameziane, B Kuskonmaz, ... Blood 130 (Supplement 1), 2464-2464, 2017 | | 2017 |
| PKNOX2 regulated by TGFbeta is a new candidate to explain bone marrow failure in fanconi anemia I Cagnan, FA Kaya, E Cosgun, Ö Konu, D Uckan-Cetinkaya, ... Experimental Hematology 53, S136, 2017 | | 2017 |
| Change in HOX gene expression by osteogenic differentiation capacity of human bone marrow derived mesenchymal stromal/stem cells I Cagnan, F Aerts-Kaya, D Uckan, AG Ozcan HUMAN GENE THERAPY 27 (11), A69-A69, 2016 | | 2016 |
| Changing the Face of Modern Medicine: Stem Cells and Gene Therapy Florence, Italy October 18–21, 2016 Abstracts JC Ramírez, AB del Campo, A Pañeda, I Jiménez, A Berlanga, A Mork, ... Human Gene Therapy 27 (11), A1-A185, 2016 | | 2016 |
| PBX/Knotted 1 Homeobox 2 is an activator and a downstream target of transforming growth factor beta-1 I Cagnan, DU Cetinkaya, A Gunel-Ozcan FEBS JOURNAL 283, 59-60, 2016 | | 2016 |
| Mesenchymal stem cells induce proliferation of NCI-H82 small cell lung cancer CZ Kopru, I Cagnan, I Akar-Soycan, G Esendagli, P Korkusuz, AG Ozcan HUMAN GENE THERAPY 26 (10), A49-A50, 2015 | | 2015 |
| ESGCT and FSGT Collaborative Congress Helsinki, Finland September 17–20, 2015 Abstracts S Sultan, A Reginald, MJ Evans, P Antonitsis, S Westaby, K Anastasiadis, ... Human Gene Therapy 26 (10), A-1-A-108, 2015 | | 2015 |
| pCR3:: GITRL transfected MSCs induce apoptotic cell death and SIVA1 expression in SCLC-21H lung cancer cell line CZ Kopru, P Korkusuz, I Cagnan, I Akar-Soycan, G Esendagli, AG Ozcan HUMAN GENE THERAPY 26 (10), A49-A49, 2015 | | 2015 |
